Metabolism of amitriptyline with CYP2D6 expressed in a human cell line

References

• BAKER, G. B., Courrs, R. T. and MARTIN, I. L. 1981, Analysis of amines in the central nervous system by gas chromatography with electron-capture detection. Progress in Neurobiology, 17, 1–24.
   PubMed Web of Science ®Google Scholar
• BROSEN, K., ZEUGIN, T. and MEYER, U. A., 1991, Role of P45011D6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clinical Pharmacology and Therapeutics, 49, 609–617.
   PubMed Web of Science ®Google Scholar
• BERTILSSON, L., MELLSTROM, B. and SJOQVIST, F., 1979, Pronounced inhibition of NA uptake by 10-hydroxy metabolites of nortriptyline. Life Sciences, 25, 1285–1292.
   PubMed Web of Science ®Google Scholar
• BREYER-PFAFF U., PFANDL, B., NILL, K., NUSSER, E., MONNEY, C., JONZIER -PEREY, M., BAETTIG, D. and BAUMANN, P., 1992, Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clinical Pharmacology and Therapeutics, 52, 350–358.
   Google Scholar
• COUTTS, R. T., Su, P. and BAKER, G. B., 1994, Involvement of CYP2D6, CYP3A4 and other cytochrome P-450 isozymes in N-dealkylationreactions. Journal ofPhannacologicaland ToxicologicalMethods, 31, 177–186.
   PubMed Web of Science ®Google Scholar
• GRACE, J. M., KINIER, M. T. and MACDONALD, T. L., 1994, A typical metabolism of deprenyl and its enantiomer, (S)-(±)-N, alpha-dimethyl- N-propynylphenethylamine, by cytochrome P450 2D6. Chemical Research in Toxicology, 7, 286–290.
   PubMed Web of Science ®Google Scholar
• HARTTER, S., WETZEL, H., HAMMES, E. and HIEMKE, C., 1993, Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology 110, 302–308.
   PubMed Web of Science ®Google Scholar
• ISLAM, S. A., WOLF, C. R., LENNARD, M. S. and S TERNBERG, M. J., 1991, A three- dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. CarcinogenesiN 12, 2211–2219.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, S., MURRAY, S., WATSON, D., SESARDIC, D., DAVIES, D. S. and Booms, A. R., 1989, The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology, 38, 2795–2799.
   PubMed Web of Science ®Google Scholar
• KRISTINSSON, J., 1981, A gas chromatographic method for the determination of antidepressant drugs in human serum. Acta Phannacologica et Toxicologic ct 49, 390–398.
   PubMed Web of Science ®Google Scholar
• LEMOINE, A., GAUTIER, J. C., AZOULAY, D., KIFFEL, L., BELLOC, C., GUENGERICH, F. P., MAUREL, P., BEAUNE, P. and LEROUX, J. P., 1993, Major pathway of imipramine is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Molecular Pharmacology, 43, 827–832.
   PubMed Web of Science ®Google Scholar
• MADSEN, H., NIELSEN, K. K. and BROSEN, K., 1995, Imipramine metabolism in relation to the spartein and mephenytoin oxidation polymorphisms—a population study. British Journal of Clinical Pharmacology, 39, 433–439.
   PubMed Web of Science ®Google Scholar
• MELLSTRO. M, B., BERTILSSON, L., Lou, Y. C., S AWE, J. and SI@ QVIST, F., 1983. Amitriptyline metabolism: Relationship to polymorphic debrisoquin hydroxylation. Clinical Pharmacology and Therapeutics, 34, 516–520.
   Google Scholar
• MELLSTRO. M, B., S AWE, J., BERIILSSON, L. and SJOQVIST, F., 1986, Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokers. Clinical Pharmacology and Therapeutics, 39, 369–371.
   Google Scholar
• MELLSTRO. M, B. and VON BAHR, C., 1981, Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug Metabolism and Disposition, 9, 565–568.
   Google Scholar
• MEYER, U. A., AmitEm, R., BALANT, L. P., BERIILSSON, L., EICHELBAUM, M., GUENTERT, T. W., HENAUER, S., JACKSON, P., L AUX, G., MIKKELSEN, H., PECK, C., POLLOCK, B. G., PRIEST, R., SJOQWST, F. and DELINI S TULA, A., 1996, Antidepressant and drug-metabolizing enzymes—expert group report. Acta Psychiatrica Scandinavica, 93, 71–79.
   Google Scholar
• MULLER, N., BROCKMOLLER J. and ROOTS, I., 1991, Extremely long plasma half-life in a woman with the cytochrome P4501ID6 29/29-kilobase wild-type allele: a slowly reversible interaction with fluoxetine. Therapeutic Drug Monitoring, 13, 533–536.
   Google Scholar
• NUSSER, E., IV-ILL, K. and BREYER -PFAFF, U., 1990, Enantiomer analysis of E- and Z- 10-hydroxyamitriptyline in human urine. Journal of Chromatography, 528, 163–171.
   Google Scholar
• PASCO, D. S., BOYUM, K. W., aim, C., Sru, C. S. and Fagan, J. B., 1993. Inducer-dependent transcriptional activation of the P4501A2 gene in vivo and in isolated hepatocytes. Journal of Biological Chemistry, 268, 1053–1057.
   PubMed Web of Science ®Google Scholar
• PFLEGER, K., MAURER, H. and WEBER, A., 1985, Mass Spectral and GC Data of Drugs, Poisons and their Metabolites Part II. Mass Spectra and Indexes (Deerfield: VCH), pp. 467, 533.
   Google Scholar
• SCHMIDER, J., GREENBLAT, D. J., VON M OLTKE, L. L., HARMATZ, J. S. and S HADER, R. I., 1995, N-demethylation of amitriptyline in vitro: role of cytochrome P-4503A (CYP3A) isoforms and effect of metabolic inhibitors. Journal of Pharmacology and Experimental Therapeutics, 275, 592–597.
   PubMed Web of Science ®Google Scholar
• SKJELBO, E. and BROSEN, K., 1992, Inhibitors of imipramine metabolism by human liver microsomes. British Journal of Clinical Pharmacology, 34,256–261.
   PubMed Web of Science ®Google Scholar
• SMITH, D. A., 1991, Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metabolism Reviews, 23, 355–373.
   PubMed Web of Science ®Google Scholar
• SPINA, E., PoLuctrvo, A. M., AVENOSO, A., CAMPO, G. M., PERUCCA, E. and CAPUTI, A. P., 1993, Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Therapeutic Drug Monitoring, 15, 243–246.
   PubMed Web of Science ®Google Scholar
• ZHANG, X. H., Yu, P., Gu, N. F., YIN, J. L. and JIANG, W. D., 1993, Relationship between amitriptyline metabolism and polymorphic debrisoquine hydroxylation in native Chinese volunteers. Acta Pharrnaceutica Sinica, 28, 85–91.
   PubMedGoogle Scholar